In one example, newborn mice lacking NF-κB inhibitor-α (IκBα/Nfkbia) developed myeloproliferative disease affecting the granulocyte, erythroid monocyte/macrophage lineages. Here, NFKBIA is linked to myeloproliferative disorder.